Here's What I Think Is Going on With Palantir Stock

Palantir’s business remains strong, with U.S. commercial customers up 42% to 615 and total contract value rising 61% to $2.4 billion. Despite these gains, the stock has fallen about 27% over the past six months and trades at 94x forward earnings, as investors worry about valuation and AI potentially commoditizing software. The article argues the pullback reflects sentiment and rotation rather than deteriorating fundamentals.

Analysis

PLTR looks like a classic post-hypergrowth digestion trade: fundamentals are still compounding, but the stock has moved far enough ahead of near-term proof that incremental buyers are hesitating. The key second-order issue is not whether the business is good; it’s whether AIP-driven adoption can keep outpacing the multiple compression that happens once a category winner becomes widely owned. That makes the next 1-2 quarters more about positioning and narrative persistence than operating execution.

The main competitive risk is subtler than “AI replaces software.” The real threat is budget reallocation toward more modular AI-native tools that sit on top of existing data stacks and win by being cheaper, faster, and easier to deploy. If that happens, PLTR can still grow, but contract quality and expansion rates matter more than headline customer counts; any slowdown in deal size or implementation velocity would hit the multiple quickly because the stock is still priced for sustained scarcity value.

The setup also creates a relative-value opportunity in the broader AI complex. If capital is rotating out of the obvious winner into under-owned infrastructure and incumbent AI beneficiaries, PLTR can underperform even while doing everything right operationally. In that regime, the better trade is often not outright shorting strength, but expressing skepticism via pairs against less expensive beneficiaries with cleaner earnings revisions and lower execution risk.

Contrarian view: the market may be overestimating how fragile PLTR’s moat is in the short run and underestimating how sticky deeply embedded workflows become once a platform is inside a regulated enterprise. The downside from here is less about business deterioration and more about duration risk: a high-multiple compounder can stay range-bound for months even with strong prints until growth re-accelerates enough to reset expectations. If the next two quarters confirm durable U.S. commercial acceleration, this could transition from de-rated leader to re-rating candidate.

Key Decisions for Investors

• Hold but do not chase PLTR into strength; use pullbacks over the next 2-6 weeks to build a starter long, with a 12-month view and a hard stop if commercial expansion metrics decelerate meaningfully.
• Relative-value trade: long PLTR / short a basket of lower-beta, lower-multiple software names likely to have less AI narrative support; target 3-6 months, aiming to capture multiple compression in the short leg rather than absolute upside in PLTR.
• For tactical risk control, sell covered calls on existing PLTR longs against 1-2 month maturities; the skew allows monetizing elevated implied volatility while the stock absorbs valuation digestion.
• If looking for cleaner AI exposure, rotate incremental capital toward NVDA on pullbacks rather than adding aggressively to PLTR; NVDA has stronger near-term earnings elasticity and less valuation fragility, though with lower asymmetry now.
• Set a catalyst watch on the next two earnings prints: if contract value and U.S. commercial growth stay >30% YoY, consider adding to PLTR on any post-earnings selloff; if growth slips below that range, reduce exposure as the multiple is unlikely to support further de-rating.